Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,892,700
+$765,982 QoQ
Shares Held
1,578
+28.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#2,543
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAMDEN NATIONAL BANK holds $48,743,727 across 8 Drug Manufacturers - General names. LLY ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,914 | $17,756,057 | |
| 2 | MRK |
Merck & Co., Inc.
|
113,039 | $14,525,511 | |
| 3 | NVS |
Novartis AG
|
70,745 | $11,087,156 | |
| 4 | ABBV |
AbbVie Inc.
|
9,869 | $2,483,434 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,578 | $1,892,700 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,850 | $360,068 | |
| 7 | PFE |
Pfizer Inc
|
14,370 | $346,029 | |
| 8 | AZN |
Astrazeneca PLC
|
1,544 | $292,772 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,892,700 | 1,578 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,126,718 | 1,225 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $1,345,499 | 1,252 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $951,461 | 1,247 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $984,545 | 1,263 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,048,905 | 1,270 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,093,152 | 1,416 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,405,986 | 1,587 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,489,349 | 1,645 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,274,298 | 1,638 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $1,001,456 | 1,718 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $944,811 | 1,759 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $853,074 | 1,819 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $636,700 | 1,854 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $685,950 | 1,875 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $620,508 | 1,919 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $622,197 | 1,919 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $549,544 | 1,919 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $907,382 | 3,285 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $755,302 | 3,269 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $998,641 | 4,351 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $853,580 | 4,569 | Shares | Defined | 2021-08-04 | |
| 2020-12-31 | $785,612 | 4,653 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $799,751 | 5,403 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $905,944 | 5,518 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $766,150 | 5,523 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||